Introduction Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART), 21 793 people were newly diagnosed with HIV in Europe in 2019. The Concerted action on seroconversion to AIDS and death in Europe study aims to understand current drivers of the HIV epidemic; factors associated with access to, and uptake of prevention methods and ART initiation; and the experiences, needs and outcomes of people with recently acquired HIV. Methods and analysis This longitudinal observational study is recruiting participants aged ≥16 years with documented laboratory evidence of HIV seroconversion from clinics in Canada and six European countries. We will analyse data from medical records, self-administered questionnaires...
Introduction In 2010, the Canadian province of British Columbia (BC) initiated the ...
Introduction: Despite a number of HIV prevention strategies, the number of new HIV infections remain...
Introduction: The HIV care cascade is increasingly used to evaluate HIV treatment programs at the po...
International audienceIntroduction Despite the availability of pre-exposure prophylaxis (PrEP) and a...
OBJECTIVES: To estimate the times from HIV seroconversion to death, and to the initiation of therapy...
BackgroundThe HIV cascade is an important framework for assessing systems of care, but population-ba...
BackgroundThe HIV cascade is an important framework for assessing systems of care, but population-ba...
Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV...
During the early 21st century HIV underwent a transition from an invariably terminal illness to a ma...
Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV...
Background: the International Cohort Consortium of Infectious Disease (RESPOND) is a collaboration d...
OBJECTIVES: To describe the HIV care cascade for Switzerland in the year 2012. DESIGN/METHODS: Six l...
Background: the International Cohort Consortium of Infectious Disease (RESPOND) is a collaboration d...
The ANRS 12249 TasP cluster-randomized trial aimed at evaluating the impact of a Universal Test and ...
OBJECTIVES: To describe the HIV care cascade for Switzerland in the year 2012. DESIGN/METHODS: Six ...
Introduction In 2010, the Canadian province of British Columbia (BC) initiated the ...
Introduction: Despite a number of HIV prevention strategies, the number of new HIV infections remain...
Introduction: The HIV care cascade is increasingly used to evaluate HIV treatment programs at the po...
International audienceIntroduction Despite the availability of pre-exposure prophylaxis (PrEP) and a...
OBJECTIVES: To estimate the times from HIV seroconversion to death, and to the initiation of therapy...
BackgroundThe HIV cascade is an important framework for assessing systems of care, but population-ba...
BackgroundThe HIV cascade is an important framework for assessing systems of care, but population-ba...
Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV...
During the early 21st century HIV underwent a transition from an invariably terminal illness to a ma...
Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV...
Background: the International Cohort Consortium of Infectious Disease (RESPOND) is a collaboration d...
OBJECTIVES: To describe the HIV care cascade for Switzerland in the year 2012. DESIGN/METHODS: Six l...
Background: the International Cohort Consortium of Infectious Disease (RESPOND) is a collaboration d...
The ANRS 12249 TasP cluster-randomized trial aimed at evaluating the impact of a Universal Test and ...
OBJECTIVES: To describe the HIV care cascade for Switzerland in the year 2012. DESIGN/METHODS: Six ...
Introduction In 2010, the Canadian province of British Columbia (BC) initiated the ...
Introduction: Despite a number of HIV prevention strategies, the number of new HIV infections remain...
Introduction: The HIV care cascade is increasingly used to evaluate HIV treatment programs at the po...